ArticleJournal for immunotherapy of cancer2021

PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8

Pu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.